SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027495
Filing Date
2016-11-04
Accepted
2016-11-04 06:08:56
Documents
75
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nvet-10q_20160930.htm 10-Q 1609621
2 EX-12.1 nvet-ex121_7.htm EX-12.1 43241
3 EX-31.1 nvet-ex311_6.htm EX-31.1 10559
4 EX-31.2 nvet-ex312_8.htm EX-31.2 10250
5 EX-32.1 nvet-ex321_10.htm EX-32.1 7632
6 EX-32.2 nvet-ex322_9.htm EX-32.2 7631
  Complete submission text file 0001564590-16-027495.txt   7155651

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT nvet-20160930.xml EX-101.INS 1774372
8 XBRL TAXONOMY EXTENSION SCHEMA nvet-20160930.xsd EX-101.SCH 55472
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvet-20160930_cal.xml EX-101.CAL 42951
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvet-20160930_def.xml EX-101.DEF 149079
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvet-20160930_lab.xml EX-101.LAB 374707
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvet-20160930_pre.xml EX-101.PRE 299756
Mailing Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98
Business Address UNIT 5, SRAGH TECHNOLOGY PARK RAHAN ROAD TULLAMORE , CO. OFFALY L2 R35 FR98 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36828 | Film No.: 161973551
SIC: 2834 Pharmaceutical Preparations